Page last updated: 2024-08-24

cidofovir anhydrous and Keratoconjunctivitis

cidofovir anhydrous has been researched along with Keratoconjunctivitis in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (16.67)	18.2507
2000's	4 (66.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Aydamirov, AS; Erdem, E; Harbiyeli, II; Ozturk, G; Yagmur, M; Yarkin, F	1
Gambotto, A; Gordon, YJ; Nwanegbo, EC; Romanowski, EG	1
Araullo-Cruz, T; Gordon, YJ; Romanowski, EG	1
Gordon, YJ; Romanowski, EG	1
Böhringer, D; Cartsburg, O; De Clercq, E; Godehardt, E; Hillenkamp, J; Reinhard, T; Roggendorf, M; Ross, RS; Sundmacher, R	2

Trials

2 trial(s) available for cidofovir anhydrous and Keratoconjunctivitis

Article	Year
Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study. Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:10 Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Treatment Outcome	2001
The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study. Ophthalmology, 2002, Volume: 109, Issue:5 Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Conjunctiva; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Eyelids; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Safety	2002

Article

Year

Topical treatment of acute adenoviral keratoconjunctivitis with 0.2% cidofovir and 1% cyclosporine: a controlled clinical pilot study.

Archives of ophthalmology (Chicago, Ill. : 1960), 2001, Volume: 119, Issue:10

Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Eye Infections, Viral; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Treatment Outcome

2001

The effects of cidofovir 1% with and without cyclosporin a 1% as a topical treatment of acute adenoviral keratoconjunctivitis: a controlled clinical pilot study.

Ophthalmology, 2002, Volume: 109, Issue:5

Topics: Acute Disease; Adenovirus Infections, Human; Adenoviruses, Human; Adult; Aged; Aged, 80 and over; Antiviral Agents; Cidofovir; Conjunctiva; Cyclosporine; Cytosine; DNA Primers; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Eyelids; Female; Humans; Immunosuppressive Agents; Keratoconjunctivitis; Male; Middle Aged; Ophthalmic Solutions; Organophosphonates; Organophosphorus Compounds; Pilot Projects; Polymerase Chain Reaction; Safety

2002

Other Studies

4 other study(ies) available for cidofovir anhydrous and Keratoconjunctivitis

Article	Year
In Vitro efficacy of cyclosporine a and various antiseptics and antiviral drugs on adenovirus genotype 8, a common cause of epidemic keratoconjunctivitis. International ophthalmology, 2023, Volume: 43, Issue:5 Topics: Adenoviridae; Adenoviridae Infections; Anti-Infective Agents, Local; Antiviral Agents; Chlorhexidine; Cidofovir; Cyclosporine; Ganciclovir; Genotype; Humans; Keratoconjunctivitis; Povidone-Iodine	2023
Efficacy of topical immunoglobulins against experimental adenoviral ocular infection. Investigative ophthalmology & visual science, 2007, Volume: 48, Issue:9 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cell Culture Techniques; Cidofovir; Conjunctiva; Cornea; Cytosine; Disease Models, Animal; Epithelial Cells; Eye Infections, Viral; Flow Cytometry; Immunoglobulins, Intravenous; Immunologic Factors; Keratoconjunctivitis; Organophosphonates; Rabbits; Treatment Outcome; Virus Cultivation; Virus Replication; Virus Shedding	2007
Topical HPMPC inhibits adenovirus type 5 in the New Zealand rabbit ocular replication model. Investigative ophthalmology & visual science, 1994, Volume: 35, Issue:12 Topics: Adenoviridae Infections; Adenoviruses, Human; Animals; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Female; Humans; Keratoconjunctivitis; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Rabbits; Virus Replication; Virus Shedding	1994
Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model. Investigative ophthalmology & visual science, 2000, Volume: 41, Issue:2 Topics: Adenovirus Infections, Human; Adenoviruses, Human; Administration, Topical; Animals; Antiviral Agents; Cidofovir; Cytosine; Eye Infections, Viral; Female; Keratoconjunctivitis; Organophosphonates; Organophosphorus Compounds; Rabbits; Viral Plaque Assay; Virus Cultivation; Virus Replication; Virus Shedding	2000